Log in to save to my catalogue

CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's di...

CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's di...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1115061928

CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease

About this item

Full title

CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2012-10, Vol.3 (1), p.1146-7, Article 1146

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

L-type calcium channels expressed in the brain are heterogeneous. The predominant class of L-type calcium channels has a Ca
V
1.2 pore-forming subunit. L-type calcium channels with a Ca
V
1.3 pore-forming subunit are much less abundant, but have been implicated in the generation of mitochondrial oxidant stress underlying pathogenesis in...

Alternative Titles

Full title

CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1115061928

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1115061928

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/ncomms2149

How to access this item